Anna Berkenblit

VP & Chief Medical Officer, ImmunoGen Inc.

Companies

Surrozen, Inc./DEBoard member Aug 16, 2021 to now¹
ImmunoGen Inc.VP & Chief Medical Officer Dec 16, 2016 to Jul 5, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ImmunoGen Inc. IMGN113,935 shares³Jun 30, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2023Granted 3,264 shares at $4.05 of ImmunoGen Inc.³
Dec 30, 2022Granted 436 shares at $3.92 of ImmunoGen Inc.⁴
Jun 30, 2022Granted 3,073 shares at $3.83 of ImmunoGen Inc.⁵
Dec 31, 2021Granted 1,761 shares at $5.60 of ImmunoGen Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSurrozen, Inc./DE, Board member
2
SEC EDGARImmunoGen Inc., VP & Chief Medical Officer
3
SEC EDGARImmunoGen Inc. shares after the filing of Jun 30, 2023
4
SEC EDGARForm 4 filed Jan 3, 2023
5
SEC EDGARForm 4 filed Jul 5, 2022
6
SEC EDGARForm 4 filed Jan 4, 2022